Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon

Indian J Pediatr. 2021 Nov;88(11):1142-1144. doi: 10.1007/s12098-021-03817-2. Epub 2021 Jun 9.

Abstract

A 3-y-3-mo old male child presented with massive hypertrophy and bluish-purple discoloration of the left upper limb and adjacent chest wall of 3 mo duration. There was no h/o fever, weight loss, painful large joint swelling, or any bleeding manifestations. He had spindle like nonprogressive, painless swelling of all fingers of the left hand since infancy. The child was moribund with microangiopathic hemolytic anemia, thrombocytopenia, and consumptive coagulopathy without sepsis. He received multiple transfusions of fresh frozen plasma (FFP), platelets, and packed RBC. Paradoxical worsening of symptoms with platelet transfusions and radiological evidences led to the diagnosis of a very rare congenital multifocal vascular tumor, kaposiform hemangioendothelioma (KHE) with Kasabach-Merritt phenomenon (KMP). The index case of KHE was multifocal with cutaneous lesions, osteolytic bony lesions of all phalanx and metacarpals of the left hand, and intrathoracic extension. It was successfully managed with a combination of steroid, vincristine and sirolimus.

Keywords: Kaposiform hemangioendothelioma (KHE); Kasabach–Merritt phenomenon (KMP); Sirolimus; Vincristine.

MeSH terms

  • Child
  • Hemangioendothelioma* / complications
  • Hemangioendothelioma* / diagnosis
  • Hemangioendothelioma* / therapy
  • Humans
  • Infant
  • Kasabach-Merritt Syndrome* / complications
  • Kasabach-Merritt Syndrome* / diagnosis
  • Kasabach-Merritt Syndrome* / therapy
  • Male
  • Sarcoma, Kaposi* / complications
  • Sarcoma, Kaposi* / diagnosis
  • Sarcoma, Kaposi* / therapy
  • Vincristine / therapeutic use

Substances

  • Vincristine

Supplementary concepts

  • Kaposiform Hemangioendothelioma